Clinical Trials in Nashville

Showing 5101-5120 of 20,298 trials

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

NCT01937117

This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which patients are most likely to respond to the combination of trastuzumab and pertuzumab when given prior to surgery.

Breast Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins88 participantsStarted Jan 2014

Birmingham, Alabama, United States • Washington D.C., District of Columbia, United States • Indianapolis, Indiana, United States +7 more locations

TERMINATEDPhase 1< 1 mile

A Study to Investigate LYL797 in Adults With Solid Tumors

NCT05274451

This study will evaluate the safety and tolerability of LYL797, a ROR1-targeted CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small cell lung cancer (NSCLC), platinum-resistant epithelial ovarian cancer/ fallopian tube cancer/ primary peritoneal cancer (Ovarian cancer), or Endometrial cancer. The first part of the study will determine the safe dose for the next part of the study, and will enroll patients with TNBC, NSCLC, Ovarian or Endometrial cancer. The second part of the study will test that dose in additional patients with TNBC, NSCLC, Ovarian or Endometrial cancer.

Triple Negative Breast CancerTNBC - Triple-Negative Breast CancerNon-small Cell Lung Cancer+20 more

Lyell Immunopharma, Inc.57 participantsStarted Mar 2022

Scottsdale, Arizona, United States • Santa Monica, California, United States • New Haven, Connecticut, United States +15 more locations

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

A Study to Investigate LYL797 in Adults With Solid Tumors

Find Trials by Condition in Nashville

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

Parallel Versus Perpendicular Technique for Lumbar Medial Branch Radiofrequency Neurotomy

Utility of PCD Diagnostics to Improve Clinical Care

Comparison of Growth and Tolerance of Healthy Term Infants Fed Iron-Fortified Infant Formulas

A Study of EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway

Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia

Study of Neoantigen-specific Adoptive T Cell Therapy for Newly Diagnosed MGMT Negative Glioblastoma Multiforme (GBM)

Pilot Study of Optune (NovoTTF-100A) for Recurrent Atypical and Anaplastic Meningioma

A Study to Investigate LYL845 in Adults With Solid Tumors

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

Vaginal Ecosystem and Network in the United States Study

Feasibility Study of the LVIS™ (Low-profile Visualized Intraluminal Support)Device

A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis

Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates